In this study, we have included ACPAs directed toward well-established peptide targets (fibrinogen, vimentin and enolase[35]) as well as newer targets (biglycan, clusterin and histones 2A and 2B), all of which have been shown to be associated with RA. Here, VIM is linked to rheumatoid arthritis.